IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/speakers.

html

IRIS 2011 Conference speakers

Home
Charles L. Rice, MD
Our Purpose President, Uniformed Services University of the Health Sciences, Bethesda, MD
About AFRRI Dr. Rice graduated with an AB from the University of Georgia in 1964 and earned his medical
Program Committee degree from the Medical College of Georgia in 1968. He interned at Bowman Gray School of
Calendar Medicine at Wake Forest University, Winston-Salem, NC. He completed his general surgery
residency at the National Naval Medical Center in Bethesda, MD, followed by a research
Agenda
fellowship at the Naval Medical Research Institute in Bethesda. Dr. Rice’s research interests,
Venue & Accomodation many funded by the National Institutes of Health, have been in the biology of lung injury and in
Conference Speakers mechanisms of cell and tissue injury in shock. His clinical focus has been in trauma and critical
Registration care. He is a diplomate of the American Board of Surgery; a Fellow of the American College of
Surgeons; a member of numerous professional organizations, including the American Surgical
Symposium Participants
Association and the Society of University Surgeons; and a past president of the Shock Society.

Abstracts Mark A. Melanson, PhD, COL, MSC, USA

Abstract Guidelines Director, Armed Forces Radiobiology Research Institute, Bethesda, MD
Submissions COL Melanson earned a Bachelor of Science in Physics from Dickinson College in Carlisle,
Deadlines Pennsylvania. After graduation, he went on to receive both his master’s and doctorate degrees
in radiation health sciences from The Johns Hopkins University School of Hygiene and Public
Release Form
Health. COL Melanson is recognized internationally as an expert in the area of radiation sciences
and has served as a consultant to both the World Health Organization and the International
Posters Atomic Energy Agency. He was also a member of a United Nations team of scientific experts
Poster Topics responsible for assessing the risks associated with NATOs use of depleted uranium munitions on
Poster Guidelines the Balkans.

Adarsh Ramakumar, PhD

Chairman IRIS, Principal Investigator & Sr. Bioinformatics Analyst,
Armed Forces Radiobiology Research Institute, Bethesda, MD
Dr. Adarsh Ramakumar is the Principal Investigator and Sr. Bioinformatics analyst of Automated
Cytogenetics lab at the Armed Forces Radiobiology Research Institute (AFRRI). His primary
responsibilities include oversight of new programs for triage of radiological mass casualty and
the development of Cytogenetic Laboratory Automated Scoring Platform (CLASP), an automated
dicentric chromosome-aberration analysis system for biological dosimetry. His group focuses on
using artificial intelligence and bayesian networks to automate classical cytogentics assays to
provide enhanced throughput for biodosimetry. Dr. Ramakumar joined AFRRI in 2008 from
Washington University School of Medicine, St. Louis, where as a Program Analyst he designed, validated and
developed pan-viral micro-array chip for detection of novel viruses and to detect viral causes of hemorrhagic fever
and encephalitis. Dr. Ramakumar started with MD at Rostov State Medical University, Russia. He received his degree
(Gold Medalist) in clinical pharmacology from University of Mysore, India. He received his Diploma in Computer
Science from Raman Computer Institute, India and his Diploma in Information Management & Business Administration
from Jyothi Institute of Business Management, India. He completed his MS In Bioinformatics from Sheffield Hallam
University, UK and his PhD in Bioinformatics with focus on genomics and artificial intelligence from University of
Bremen, Germany. Dr. Ramakumar is a recipient of numerous prestigious honors, meritorious awards and fellowships.

William F. Blakely, PhD

Senior Scientist, Biological Dosimetry Research Program Advisor,
Armed Forces Radiobiology Research Institute, Bethesda, MD
Dr. Blakely earned a Doctor of Philosophy in Radiation Biology from the University of Illinois at
Urbana-Champaign. He went on to complete postdoctoral studies in DNA radiation chemistry in
Dr. John F. Wards laboratory at the University of California, San Diego. In 1983, Dr. Blakely
joined the Armed Forces Radiobiology Research Institute (AFRRI), where he remains today. His
research activities have focused on molecular mechanisms of radiation sensitivity, cell-cycle
effects, DNA damage and repair, and biological dosimetry. Dr. Blakely is currently the
Biodosimetry Research Group Advisor for AFRRI, a representative on the ISO TC85/SC2
(Radiation Protection) Working Group 18 (Performing Criteria for Service Laboratories Performing Biological Dosimetry
by Cytogenetics), former chair of a NATO Research Study Group on Radiation Bioeffects and Countermeasures
(RTG-033), and serves on the council for the National Council on Radiation Protection & Measurements (NCRP).

Carolyn J. Fisher, PhD

Research Scientist, Armed Forces Radiobiology Research Institute, Bethesda, MD

1 of 9 5/2/2011 9:16 PM
IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/speakers.html

Dr. Fisher initially pursued a career as a Chemist in the utility industry following graduation
from South Carolina State University with a BS in Chemistry. After several years of working with
radioactive material and excelling in that environment which included a supervisory role in
nuclear power, she later became interested in radiation biology. She went on to receive a MS in
Pharmacology/Toxicology from Florida A&M University where she studied the key intermediary
molecules produced by radiation: reactive oxygen species (ROS). Her project focused on the
influence of diet and manganese on ROS in rats. Dr Fisher’s studies then led her to the University
of Iowa where she obtained a PhD in Free Radical and Radiation Biology investigating the
involvement of free radical-signaling in cell cycle progression of cancer cells using in vitro cell culture systems
following radiation. Dr. Fisher has also performed postdoctoral research at Duke University using sophisticated mouse
models of primary cancers to study radiation biology.

Sree Kumar K., MSc, PhD

Senior Research Scientist, Scientific Research Department,
Armed Forces Radiobiology Research Institute, Bethesda, MD
Dr. Kumar earned a Bachelor of Science in Chemistry and Physics from Kerala University in India.
After graduation, he went on to receive both his master’s and doctorate degrees in Biochemistry
from Lucknow University in India. Dr Kumar did his post-doctoral fellowships in Pharmacology
and Nutrition at USC School of Medicine, Angeles, CA and UM School of Medicine, Miami, FL. He
was a Senior Research Associate of National Research Council-US National Academy of Sciences
in AFRRI and continues in AFRRI as a Principal Investigator/Senior Research Scientist. He has
applied his extensive training in free radical biochemistry to develop lead drug candidates as
radioprotectants and is internationally recognized for his work on gamma-tocotrienol and benzyl sulfones as
radioprotectants. He had been invited to deliver lectures in England, Germany, Hungary, India, Japan, Mexico,
Malaysia, and Ukraine. He is a member of academic committees and professional organizations. His research is
supported by several grants from Defense Threat Reduction Agency.

Noelle F. Metting, ScD

Program Manager, Sr. Radiation Biologist for the Office of Science,
Low Dose Radiation Research Program, Department of Energy, Washington, DC
Dr. Metting earned a Bachelor of Arts from Whitman College in Walla Walla, Washington, a
Masters in Radiological Sciences from the University of Washington, and a Science Doctorate in
Cancer Biology from Harvard University, School of Public Health. Prior to working for the federal
government she conducted internationally recognized research at Pacific Northwest National
Laboratory, working initially in the field of experimental microdosimetry of heavy ion beams
produced at PNNL, the Berkeley BEVALAC, and the GSI Darmstadt. Her subsequent DOE/NASA
funded research focused on cellular and molecular biology of heavy ion exposures, conducted at
the Columbia University RARAF and the Brookhaven National Laboratory Alternating Gradient Synchrotron.

Ruth Wilkins, PhD

Research Scientist, Division Chief, Radiobiology, Health Canada, Ottawa, Canada
Dr. Ruth Wilkins earned a Doctor of Philosophy in Medical Physics from the Carleton University,
Ottawa, Canada after which she joined the Consumer and Clinical Radiation Protection Bureau,
Health Canada, as a Research Scientist. Since 2006, she has been the Division Chief of the
Radiobiology Division at Health Canada. Her research involves the biological effects ionizing
radiation in mammalian systems both in vitro and in vivo with a strong focus on cytogenetic
biological dosimetry. She is currently the lead of the development of the Canadian National
Biological Dosimetry Response Plan for large scale exposures to ionizing radiation in which
Canada has developed a network of laboratories which can provide rapid dosimetry during large
scale events. Her current research interests include the development of new, higher throughput methods for
biological dosimetry.

Mitsuaki Yoshida, PhD

Professor in the Department of Radiation Biology,
Institute of Radiation Emergency Medicine, Hirosaki University, Hirosaki, Japan
Dr. Yoshida earned a Doctor of Philosophy in Cancer Cytogenetics from Hokkaido University in
Sapporo, Japan. After graduating, he joined Roswell Park Memorial Institute in New York.
Several years later, Dr. Yoshida returned to Japan to work at the Medical Research Institute of
Tokyo Medical and Dental University before joining the National Institute of Radiological
Sciences as head of the Biological Dosimetry Section. In 2010, Dr. Yoshida joined the Institute of
Radiation Emergency Medicine at Hirosaki University and is currently working to establish a
cytogenetic biodosimetry system for the university and is primarily focused on cytogenetic
biodosimetry and radiation induced carcinogenesis education and research. He is a member of a chromosome network
in Japan for cytogenetic biodosimetry and the ISO TC85/SC2 (Radiation Protection) Working Group 18 (Biological
Dosimetry). Furthermore, Dr. Yoshida is on a World Health Organization steering committee working to develop an
International Biological Dosimetry Network. He was also recently elected as the member of the Scientific Committee
of the International Association of Biological and EPR Radiation Dosimetry.

John F. Kalinich, PhD

Research Biologist, Program Advisor,
Armed Forces Radiobiology Research Institute, Bethesda, MD
Dr. John F. Kalinich received a B.S. in Biochemistry from the University of Scranton, a M.S. in
Biochemistry from Catholic University in Washington, DC, and a PhD in Chemistry from American
University. He was a Robert A. Welch post-doctoral fellow at the University of Texas
Southwestern Medical Center in Dallas, after which he joined the staff of the Armed Forces
Radiobiology Research Institute (AFRRI) in Bethesda, MD. He is currently the Program Advisor for
the Internal Contamination and Metal Toxicity Program at AFRRI.

2 of 9 5/2/2011 9:16 PM
IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/speakers.html

Shilpa S. Kulkarni, PhD

Staff Investigator, Radiation Countermeasure Program,
Armed Forces Radiobiology Research Institute, Bethesda, MD
Dr. Shilpa Kulkarni earned her B.Sc. from Mumbai University and M.Sc. from Indian Institute of
Technology (Mumbai) in Chemistry. After graduating from IIT, she went on to pursue her
doctorate degree in Biochemistry at University of Illinois at Chicago. She was a postdoctoral
fellow at National Cancer Institute-Frederick, after which, she joined AFRRI as a staff
investigator in November 2007. At AFRRI, she is involved in efficacy and mechanistic studies of
vitamin E isoform- gamma tocotrienol, with an emphasis on hematopoietic injury and stem cells
biology.

Sanchita Ghosh, PhD

Principal Investigator, Armed Forces Radiobiology Research Institute, Bethesda, MD
Dr. Ghosh earned a PhD in Chemistry from Jadavpur University, India. She did her postdoctoral
fellowship at Kent State University, Ohio. After that Dr. Ghosh joined as a research fellow in
NIDCD (National Institute of Defense and other Communications Disorder), NIH. She joined to
AFRRI in 2005 as a Research Investigator in Radiation Countermeasure Program and became
Principal Investigator in 2009. Dr. Ghosh’s research involves development and studying
mechanism of two countermeasures, Ex-RAD and GT3. She is also in-charge of the AFRRI
Intramural screening program.

Prakash Hande, PhD, MPH

Associate Professor, Department of Physiology, Yong Loo Lin School of Medicine,
National University of Singapore, Singapore
Dr. Hande obtained his Bachelor of Science in Biology from Mangalore University and Masters
Degree in Zoology from University of Mysore. He earned his PhD in Radiation Biology from
Kasturba Medical College, Manipal, India. Dr. Hande had developed a mouse model for
retrospective biological dosimetry for ionizing radiation exposure. This was further
substantiated by his work identifying genomic signatures of occupational exposures to plutonium
in a human population. He has published more than 100 peer-reviewed research articles in
international journals such as Nature Genetics, Current Biology, Journal of Cell Biology,
American Journal of Human Genetics, Cell, PNAS and Science. His research is focused on the following: DNA repair
factors and Telomeres, Oxidative damage at telomeres, Cancer biology with special emphasis on mechanism-based
growth inhibition in tumour cells, Toxicogenomic approaches to study the effects of environmental pollutants
(including ionizing radiation) in human cells. Dr. Hande is one of the founding Editors-in-Chief of Genome Integrity—a
Biomedcentral Journal.

Sally Amundson, PhD

Associate Professor, Center for Radiological Research, Dept. of Radiation Oncology,
Columbia University Medical Center, New York, NY
Dr. Amundson earned a Bachelor’s Degree from Hamline University in St. Paul, Minnesota, and
her doctorate degree in radiation and cancer biology from The Harvard School of Public Health
in Boston. Dr. Amundson is internationally recognized as an expert in the area of radiation
biology, serving on the Scientific Council of the Radiation Effects Research Foundation (RERF) in
Hiroshima Japan, and on Program Area Committee 1 of the National Council on Radiation
Protection and Measurements (NCRP), of which she has been a member since 2004. She is also a
winner of the Michael Fry Research Award of the Radiation Research Society, and an Associate
Editor of the journal Radiation Research. Her current work focuses on signal transduction and gene expression
networks in radiation response.

Albert Fornance, Jr., PhD

Professor & Chair of Molecular Cancer Research, Lombardi Comprehensive Cancer Center,
Georgetown University, Washington, DC
Dr. Fornace is currently serving as Chair of Molecular Cancer Research at the Lombardi
Comprehensive Cancer Center at Georgetown University Medical Center. He joined Georgetown
in 2006 from the Harvard School of Public Health, where he was the director of the John B. Little
Center for the Radiation Sciences and Environmental Health. As the Molecular Cancer Research
Chair, he is investigating what happens to cells when they are stressed or injured by anything
from toxic substances to aberrantly expressing oncogenes work that has thus far revealed
processes underlying development of cancer and other diseases. In addition to his research on
the molecular pathways of cancer, Dr. Fornace is also studying cellular stress responses on a broader level. By
understanding genome-wide response to stresses like radiation or chemical toxins, he will be able to develop
biomarkers to detect exposure in humans. He is specifically looking for markers in both gene expression and
metabolites which can be detected in easily obtainable samples like urine, blood, and saliva. With this kind of test
available, emergency response personnel would be able to identify and triage patients who were significantly
exposed.

Mark H. Whitnall, PhD

Program Advisor, Radiation Countermeasures,
Armed Forces Radiobiology Research Institute, Bethesda, MD
Dr. Whitnall received an A.B. in Psychology from Brown University, and a PhD in Physiology from
the Cornell University Graduate School of Medical Sciences. He was a Postdoctoral Fellow, Staff
Fellow, and Senior Staff Fellow at the National Institutes of Health; and the Program Manager
for Developmental Neuroscience at the National Science Foundation. Dr. Whitnall joined the
staff of the Armed Forces Radiobiology Research Institute (AFRRI) in Bethesda, MD in 1990. He
serves on a number of national and international panels and peer review committees that guide
policy and funding of radiation countermeasure research and development. His research

3 of 9 5/2/2011 9:16 PM
IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/speakers.html

interests include development of the minipig as a model for radiation countermeasure development, the effects of
radiation quality on countermeasure efficacy, and the cellular and molecular mechanisms of the hematopoietic
microenvironment.

William T. Phillips, PhD

Professor, Director of Nanoparticle Imaging/Therapeutic Systems, Department of Radiology,
University of Texas Health Science Center at San Antonio, San Antonio, TX
Dr. Phillips received his MD degree from the University of Texas Medical Branch in Galveston and
his Nuclear Medicine physician training at the University of Texas HSC-San Antonio. He is
recognized internationally as an expert in nanotechnology, nuclear imaging and drug delivery.
He has been developing methods to image nanoparticles for more than 20 years with more than
100 peer-reviewed articles in the fields of imaging and nanoparticle drug delivery. Using
imaging, he has developed nanoparticle systems that are targeted to bone marrow, lymph
nodes, tumors, inflammation and peritoneal/pleural body cavities. He has also worked with
colleagues to develop methods of delivering therapeutic radionuclides via liposomal nanoparticles for treatment of
cancer. As a nuclear medicine physician, he has a great interest in radionuclide radiobiology and the potential use of
nanoparticles for the delivery of radioprotectants.

David Boothman, PhD

Professor, Associate Director for Translational Research,
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Dr. Boothman is currently Professor, Department of Pharmacology and Associate Director for
Translational Research at the Simmons Cancer Center. He received his Doctoral degree in
Microbiology & Immunology (1986) from University of Miami, Coral Gables, FL. He did his post
doctoral research at Harvard Medical School. He served as Associate professor at University of
Michigan, University of Wisconsin-Madison, U. W.- Madison. He served as Professor at the Ireland
Comprehensive Cancer Center. He was Associate Director for Basic Research and received
Distinguished Investigator Award, CWRU-UH Comprehensive Cancer Center, CWRU. He has more
than 110 peer-reviewed publications to his credit.

Shrikant Anant, PhD

Professor, Associate Director, Prevention and Cancer Control, Associate Dean for Research,
University of Kansas School of Medicine, Kansas City, KS
Dr. Anant is currently the Associate Director for Prevention and Cancer Control at the University
of Kansas Cancer Center and Professor in the Department of Internal Medicine and Molecular and
Integrative Physiology at the University of Kansas Medical Center. In addition Dr. Anant is a
Kansas Mason Professor of Cancer Research and has been named a Kansas Bioscience Authority
Eminent Scholar. He earned his PhD from the University of Illinois at Chicago in Molecular
Genetics in 1993. He worked as a post doctoral research fellow in the Departments of
Biochemistry and Molecular Biology and Medicine in the University of Chicago, Chicago, IL. He
has served as Assistant Professor of Medicine in the Washington University School of Medicine St. Louis, MO. He has
also held diverse positions as Associate Professor of Medicine, Director of Gastroenterology Research, Program
Leader, Gastrointestinal Cancer, OU Cancer Institute OUHSC., Oklahoma City, OK. Dr. Anant has over 75 peer
reviewed publications to his credit. He has 4 RO1 grants that he is working on right now.

Lynette H. Cary, PhD

Research Assistant Professor, Armed Forces Radiobiology Research Institute, Bethesda, MD
Dr. Cary earned a Bachelor of Science in Biology from Virginia Commonwealth University in
Richmond, Virginia. After graduation, she received a doctorate degree in Molecular and Cell
Biology from The University of MD at College Park. She joined the National Cancer Institute at
Frederick as a postdoctoral fellow, and was an Instructor at the University of CO at Denver
Health Sciences Center. She joined AFRRI in December 2007, and is currently investigating the
effects of mixed field irradiation on bone marrow progenitor and supportive cells.

Eric J. Lombardini, MAJ, VMD, MSc, DACVPM, DACVP

Chief, Division of Comparative Pathology,
Armed Forces Radiobiology Research Institute, Bethesda, MD
Major Lombardini received several degrees from the University of Pennsylvania in Philadelphia,
to include a joint bachelor’s degree in African and Middle Eastern history and in rural
development, followed by a Master of Science examining the epidemiology of morbilliviruses
between domestic and wild hoofstock, and finally his veterinary degree with an emphasis in
public health. Following his commission into the US Army Veterinary Corps, he graduated from a
residency in Veterinary Pathology at the Armed Forces Institute of Pathology and was
successfully boarded in both Veterinary Preventive Medicine and in Veterinary Pathology. He is
the recipient of the University of Pennsylvania’s prestigious Leonard Pearson award as well as
AFIP’s CL Davis award for excellence and recently received honorary membership in the Brazilian Association of
Veterinary Pathology. Dr. Lombardini is a faculty member of the Charles L Davis foundation and lectures
internationally as a subject matter expert in aquatic pathology and on the pathology of zoonotic diseases. In 2009, he
joined the AFRRI staff as the Veterinary Pathologist for the Institute.

Gordon Livingston, PhD

Technical Director, Cytogenetic Biodosimetry Laboratory,
Radiation Emergency Assistance Center/Training Site, Oak Ridge, TN
Dr. Livingston obtained B.S. and M.S. degrees from Utah State and Oregon State Universities,
respectively, and a PhD in genetics from the University of Washington in Seattle followed by a
post-doctoral fellowship in radiobiology at the University of Nijmegen in the Netherlands. He has
held faculty positions in environmental and occupational health at the University of Cincinnati

4 of 9 5/2/2011 9:16 PM
IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/speakers.html

and the University of Utah where he also served four years as the technical director of the
clinical cytogenetics laboratory in the Department of Pediatrics. His research is focused on
human cytogenetic responses to environmental adversity including environmental, occupational
and medical exposures to ionizing radiation. Examples include a radiobiological evaluation of families living near
Chernobyl at the time of the accident, occupational exposure to alpha radiation and its effect on chromosome
aberration rates in former plutonium workers and studies on the cytogenetic effects of radiation ablative therapy on
patients treated with I131 for thyroid cancers. Before joining REAC/TS he held a National Research Council Senior
Research Associateship sponsored by NIOSH in Cincinnati, Ohio.

Peter Rogan, PhD

Professor and Canada Research Chair, Genome Bioinformatics,
The University of Western Ontario, Ontario, Canada
Dr. Rogan is an internationally recognized researcher in human genomics and bioinformatics who
has authored more than 100 scientific publications and 10 patents. His interests lie in novel
approaches for interpretation genomic sequence variation and for molecular cytogenetics.
Rogan is president of Cytognomix (London ON) and previously founded Phylogenetix
Laboratories, a US company. His team of collaborators have recently developed accurate
methods to automate detection of dicentric chromosomes. He is currently Professor of
Biochemistry at the Schulich School of Medicine and Dentistry, and holds the Canada Research
Chair in Genome Bioinformatics. Dr. Rogan received his Mphil and PhD in Molecular Biophysics and Biochemistry from
Yale, and holds degrees from the University of Grenoble and Johns Hopkins University.

Rao Papineni, PhD

Sr. Principal Investigator, Research and Development,
Carestream Molecular Imaging, Woodbridge, CT
Dr. Rao V. L. Papineni is currently the Senior Principal Investigator, Research and Development,
at Carestream Health Inc, USA. He received his doctoral degree in Biochemistry from University
of Hong Kong (British Terr). Dr. Papineni had his early education from University of Madras,
where he earned his Bachelors and Masters degree. After ten years in Research and Faculty
positions at University of Hong Kong and Baylor college of Medicine (USA), he joined Kodak, USA
four years ago. He has initiated advanced research programs to study Inflammation and
musculo-skeletal biology utilizing molecular imaging and nanotechnology based molecular tools.
Dr. Papineni has made several inventions and chaired scientific sessions in International Biomedical Meetings and
serves on the editorial board of Nanotech and Experimental Pharmacology journals.

Juliann G. Kiang, PhD

Program Advisor, Prof. of Radiation Biology, Armed Forces Radiobiology Research Institute,
Bethesda, MD
Dr. Kiang earned a Bachelor of Science in Biology from Fu-Jen Catholic University in Taipei,
Taiwan. After graduation, she went on to receive her master’s degree in Biology from University
of Nebraska at Omaha and doctorate degree in Environmental Health Sciences from University
of California School of Public Health, Berkeley, California. Dr. Kiang is recognized as an expert in
the area of heat shock proteins and signal transduction under hypoxia and after radiation
combined injury. Among her many awards are the US Army Research and Development Award for
Outstanding Achievement, the US DoD Women STEM Award for Science in Excellence, and the
Order of Military Medical Merit for significant contribution to military medicine. Dr. Kiang has published several book
and peer reviewed papers.

Ian C. Dews, PhD, CPT, MS, USA

Research Biochemist, Armed Forces Radiobiology Research Institute, Bethesda, MD
CPT Ian C. Dews earned his PhD in the field of Biochemistry and cellular biology (2008). He
served as Research assistant at Washington state university and Oregon health sciences
university before joining as Mt. St. Helens field scientist at Washington state university,
Vancouver. He joined Armed Forces Radiobiology Research Institute in 2009 as a Research
Biochemist. He has published many peer-reviewed scientific papers.

Chandan Guha, MD, PhD

Professor, Vice Chair, Department of Radiation Oncology,
Albert Einstein College of Medicine, Bronx, NY, Montefiore Medical Center, Bronx, NY
Dr. Guha received his PhD degree in Immunology from the Medical University of South Carolina,
Charleston (1993). He is presently serving as Vice Chair and Professor of Radiation Oncology at
Albert Einstein College of Medicine, and he is the Director of Translational Research in the
Department of Radiation Oncology at Montefiore Medical Center. He received many awards and
scholarships as a recognition to his contributions. Presently, he is a Principal Investigator of the
NIAID grant project “Stem Cell-Based Therapies for Mitigation of Acute Radiation”. He has more
than 50 peer reviewed publications to his credit.

Harvey Pollard, MD, PhD

Professor and Chair, Department of Anatomy, Physiology and Genetics,
Uniformed Services University of the Health Sciences, Bethesda, MD
Dr. Pollard earned a Bachelor of Science degree in Biology from Rice University in Houston,
Texas. Following graduation he went to the University of Chicago, where he received both his
M.D. and PhD (Biochemistry) degrees. Dr. Pollard, now in the USPHS, then pursued postgraduate
fellowship training at the National Institutes of Health (Bethesda, MD), and at Oxford University
(U.K.), before returning to the NIH. Subsequently, Dr. Pollard came to USUHS as Professor and
Chair. Dr. Pollard’s present research interests are in proteomics and genomics as biomarkers of

5 of 9 5/2/2011 9:16 PM
IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/speakers.html

disease.

Sunil Krishnan, MD
Associate Professor, Radiation Oncology, MD Anderson Cancer Center, Houston, TX
Dr. Krishnan received his medical degree from Christian Medical College, Vellore, India and
completed an internal medicine residency at Penn State Geisinger Medical Center, Danville,
Pennsylvania followed by a radiation oncology residency at Mayo Clinic, Rochester, Minnesota.
His clinical focus is on treatment of gastrointestinal cancers. His laboratory focus is on
integrating tumor-specific targeting, image- guidance and radiosensitizing approaches using
conjugated nanoparticles. He has served as the chair of the gastrointestinal scientific program
committee of ASTRO, the co-chair of the gastrointestinal translational research program of
RTOG, councilor for the Society for Thermal Medicine, and consultant to IAEA.

Frederic Zenhausen, PhD

Professor, Director, Center for Applied Nanobioscience and Medicine,
College of Medicine Phoenix, University of Arizona, AZ
Dr. Zenhausern is Endowed Chair Professor at the Basic Medical Sciences Department, College of
Medicine, Phoenix, and he is Director of the Center for Applied Nanobioscience and Medicine,
both at the University of Arizona. Prior, Zenhausern was director of the Center for Applied
Nanobioscience at Arizona State University’s Biodesign Institute, and R&D director of the Center
for Flexible Display. He was tenured Professor with both the Electrical Department and the
School of Materials at the School of Engineering. He is Professor and Associate Director of
Molecular Diagnostics and Target Validation Division at the Translational Genomics Research
Institute, and Director of the Laboratory for Research in Personalized Medicine at the Scottsdale
Clinical Research Institute. He received his B.S. in biochemistry from the University of Geneva,
his M.B.A. in finance from Rutgers University and his Doctorate Es Science in Applied Physics at the University of
Geneva, Switzerland. Over 10 years, he held corporate research positions at IBM Research Division, Motorola Labs. He
has co-authored 70 scientific publications and over a dozen U.S. patents. Dr. Zenhausern is also the co-founder of
three biotech startups and member of a few corporate boards.

Seth Cohen, PhD

Senior Director, Microfluidic Applications and Support, Caliper Life Sciences, Hopkinton, MA
Dr. Cohen received his PhD in Microbiology from the University of Georgia, Athens and then went
on to post-doctoral research at Tufts University School of Medicine in Boston where he studied
the physiology, genetics and biochemistry of multiple drug resistant bacteria with Dr. Stuart
Levy. Following his post-doctoral research, Dr. Cohen developed DNA probes and assays for
infectious disease diagnostics at Gene-Trak Systems in Framingham MA before joining
Millennium Pharmaceuticals in Cambridge MA in 1997, initially helping to build and lead the HTS
group and finally serving as the Program Director for Millennium’s Lead Discovery department.
Dr. Cohen joined Caliper Life Sciences in late 2003 and in his current position as Senior Director
is responsible for global microfluidic applications development and technical support.

Michael R. Landauer, PhD

Senior Scientist, Armed Forces Radiobiology Research Institute, Bethesda, MD
Dr. Landauer received his Bachelor of Science degree from Rutgers University (New Brunswick,
NJ) in Animal Science and a Ph.D. from the University of Illinois (Urbana, IL) in Zoology. He was
awarded a postdoctoral fellowship from the Medical College of Virginia (Richmond, VA) in
Behavioral Toxicology Prior to joining the AFRRI staff, Dr. Landauer was a member of the
Toxicology Department at the U.S. Army Chemical Research and Development Center, at
Aberdeen Proving Ground (Edgewood, MD). He is past president of the Association of
Government Toxicologists and the recipient of the 2007 AFRRI Radiobiology Research Award. Dr.
Landauer’s research interests include the development and toxicological assessment of
potential medical radiation countermeasure agents.

Michael P. Dempsey, Lt Col, USAF, BSC, PhD

Chief, Scientific Operations & Research Support Group,
Armed Forces Radiobiology Research Institute, Bethesda, MD
Lt Col Dempsey earned his Bachelor’s degree in Biology from the University of Nebraska at
Omaha, and completed his Master’s degree in Pathology and Microbiology and his clinical
Medical Technology certification at the University of Nebraska Medical Center prior to entering
the Air Force as a Biomedical Sciences Corps lab officer. After three assignments, two in clinical
lab medicine and one in research, he went on to complete his PhD in molecular microbiology
from the University of Nebraska Medical Center. Since earning his PhD, Lt Col Dempsey has
served as a CBRN advisor to the Air Force Surgeon General in bio-defense, and he served as the
Senior Scientist of the Epidemic Outbreak Surveillance program. His understanding of, and expertise in CBRN have
been significantly enhanced during his current assignment at AFRRI. In his current role, he has helped lead AFRRI’s
scientific direction at the research, operational, and administrative levels. Further, he has significantly helped
facilitate the alignment of AFRRI’s world-renowned Radiobiology expertise with DoD operational requirements to
support the warfighter and first responder communities.

Erik Young, PhD

Postdoctoral Research Scientist, Center for Radiological Research at Columbia University,
New York, NY
Dr. Young completed a degree in Biochemistry at Loyola Marymount University before
undertaking a doctorate in cell and molecular biology at Columbia. After graduation, he joined a
team pursuing the development of a bioelectric breast cancer detection technology and has
returned, leveraging that experience forward into the development of bioimpedance and

6 of 9 5/2/2011 9:16 PM
IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/speakers.html

biological sensing modalities in radiation biology. His research interests include sensor
development and the mechanisms by which damage and damage information is transduced in
living systems.

Ramesh Rangachar, PhD

Sr. Project Head, Intelsat, Washington, DC
Dr. Rangachar works as Senior Manager, Satellite Control Systems at Intelsat. Intelsat operates
74 Intelsat-owned and third party satellites. Ramesh has over 20 years of experience in the
design and implementation of satellite ground systems. He is leading a team of IT professionals
responsible for System Integration and IT support for Intelsat Satellite Operations. He is also the
Project Manager for ground system readiness to support several new satellites. Ramesh has also
worked as Adjunct Assistant Professor at the University of Maryland, University College and as a
guest researcher at the National Institute of Standards and Technology. He has a Masters in
Mechanical Engineering from the University of Maryland.

Bruce Seligmann, PhD

Founder, Vice President of Research & Development,
Chief Scientific Officer, HTG Molecular Diagnostics, Tucson, AZ
Dr. Seligmann began his scientific career at the NIH-NIAID, Laboratory of Clinical Investigation,
and then joined Ciba-Geigy (Novartis), where he led the drug discovery programs within the
Department of Molecular Biology, Inflammation, and Osteoarthritis Research. He went on to join
a start-up biotech company, Selectide, where, as V.P. of R&D, he initiated the development of
non-peptide small molecule combinatorial chemistry (combichem) and established drug
discovery programs, producing a novel Factor Xa drug that advanced into clinical trials. After
serving as Center Director upon the acquisition of Selectide by MMD (Aventis), Dr. Seligmann
founded Systems Integration Drug Discovery Company (SIDDCO), a combinatorial chemistry
consortium, and HTG. SIDDCO was sold to Discovery Partners International and HTG, which was
focused on the development, commercialized, and marketing of the quantitative Nuclease Protection Assay (qNPA™),
was divested to SIDDCO shareholders. qNPATM enables the accurate and sensitive measurement of genes from any
sample, including FFPE, and consequently HTG and its clients are engaged in translational medicine programs to
identify biomarkers and subsequently development projects to launch diagnostic assays, including companion
diagnostic assays. Under his leadership and that of the HTG leadership team, HTG has leveraged its extensive
experience in developing and commercializing new products, including new platforms such as the X-MAP qBead assay,
whole transcriptome miRNA assay, and a surrogate whole transcriptome mRNA assay, as well as research use only
reagents that can be used by CLIA labs to develop Laboratory Developed Tests (LDT’s), and the development of IVD’s.
HTG Molecular continues to advance the qNPA™ technology, for diagnostics and research.

Pataje Prasana, PhD

Program Director, Radiation Research Program, Division of Cancer Treatment and Diagnosis,
National Cancer Institute, Rockville, MD
Pataje G. Prasanna received his doctorate in Radiobiology from India. He held a faculty position
at the Kasturba Medical College, Manipal, India, before availing himself of a U.S. National
Academy of Science’s National Research Council post- doctoral Research Associateship at the
Armed Forces Radiobiology Research Institute (AFRRI) in Maryland. As a post-doctoral research
associate he established a molecular cytogenetic laboratory at AFRRI to study genotoxic and
clastogenic effects of ionizing radiation and chemical agents. Subsequently, he worked at AFRRI,
as a Scientist for the Henry M Jackson Foundation, Rockville, MD, conducting research in
biological dosimetry as well as assessing radiation dose to individuals accidentally exposed to ionizing radiation. Most
recently he worked as a Research Biologist at AFRRI, serving as a Principal Investigator of Department of Defense in
radiationl biology and related fields in intramural and extramural research projects. As a subject matter expert in
biological dosimetry he is participating in several national and international research efforts in biological dosimetry.
He serves as a consultant to the International Atomic Energy Agency in cytogenetic biodosimetry. He joined NCI in
2009 and currently oversees a portfolio of grants, which study radiation-induced normal tissue injury, radiation
protection, radioimmunotherapy, nanotechnology, boron-neutron capture therapy, and radiogenomics.

Steven Kaminsky, PhD

Vice President for Research, Uniformed Services University of the Health Sciences,
Bethesda, MD
Dr. Kaminsky earned his B.S. in Biology from Hobart College in Geneva, New York, his M.S. in
Biology from Northern Michigan University in Marquette, Michigan, and his Ph.D. in Pathology
from the State University of New York at Buffalo. Dr. Kaminsky is the President for Research at
the Uniformed Services University of Health Sciences.

Susan Gregurick, PhD

Program Manager, Computational Biology and Bioinformatics,
Office of Biological and Environmental Research, Department of Energy, Washington, DC
Dr. Gregurick earned a Bachelor of Science in Chemistry and Mathematics from the University of
Michigan and her PhD in Physical Chemistry at the University of Maryland. Dr. Gregurick was a
Lady Davis Postdoctoral Fellow at the Hebrew University and a Sloan Postdoctoral Fellow at the
Center for Advanced Research in Biotechnology. She was a Professor at the University of
Maryland, Baltimore County with research interest in computational biophysics and currently is
a program manager with the Department of Energy. Dr. Gregurick is leading the DOEs effort in
developing a Systems Biology Knowledgebase for energy and the environment. The
Knowledgebase is a cyber-infrastructure to integrate, search, and visualize experimental data,
metadata, corresponding models, and analysis tools in an open environment.

Richard J. Hatchet, PhD

7 of 9 5/2/2011 9:16 PM
IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/speakers.html

Chief Medical Officer & Deputy Director, HHS/OS/ASPR/BARDA, Washington, DC

Dr. Hatchett is Chief Medical Officer and Deputy Director for Strategic Sciences and Management
at the Biomedical Advanced Research and Development Authority (BARDA) within the U.S.
Department of Health and Human Services. His primary responsibilities include oversight of
programs relating to strategic science and innovation, strategic affairs and reporting, the
development of science and preparedness policy, human resources, communications, and
organizational marketing. Previously, he served as Director for Medical Preparedness Policy on
the White House National Security Staff where he worked on a wide array of issues related to
medical countermeasures development, the 2009-H1N1 pandemic, and pandemic preparedness
more broadly. In 2005-6, he served as Director for Biodefense Policy on the White House Homeland Security Council
and was a principal author of the National Strategy for Pandemic Influenza Implementation Plan. In this capacity, he
helped set policy and devise strategies to mitigate the consequences of a pandemic and promote pandemic
preparedness. From 2005 – 2011, he served as Associate Director for Radiation Countermeasures Research and
Emergency Preparedness at the National Institute of Allergy and Infectious Diseases. Dr. Hatchett completed his
undergraduate and medical educations at Vanderbilt University, an internship and residency in Internal Medicine at
New York Hospital–Cornell Medical Center, and a fellowship in Medical Oncology at the Duke University Medical
Center.

Bert W. Maidment, Jr., PhD

Associate Director for Product Development, Radiation/Nuclear Medical Countermeasures
Research and Product Development Program, NIH, NAID, Division of Allergy, Immunology,
and Transplantation, Rockville, MD
Dr. Maidment received a PhD in Experimental Pathology and an M.S. from the State University of
New York-Buffalo, Roswell Park Cancer Institute. He provides scientific and program leadership
to the National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division
of Allergy, Immunology and Transplantation Product Development group for the development of
medical countermeasures to increase survival and mitigate injuries due to radiation exposure.
He manages the Radiation/Nuclear Medical Countermeasure Research and Product Development
group staff and coordinates with representatives of other government agencies to design and implement research and
development projects to complete regulatory submissions that support FDA approvals for products for the Strategic
National Stockpile. Previously, he was Vice President for Corporate Business Development at the Midwest Research
Institute (MRI) in Kansas City, Missouri. Dr. Maidment was Vice President for Operations and Marketing with LIM
Laboratories in Richmond, Virginia. He developed strategies for commercializing technologies in immunoassay,
microencapsulation, cell culture serum substitute media, and clinical analyte measurement. Dr. Maidment was
cofounder and Vice President for Product Development of NYGene Corporation in Yonkers, New York.

Maria Julia Marinissen, PhD

Director, Division of International Health Security, Office of Assistant Secretary for
Preparedness and Response, HHS, Washington, DC
Dr. Maria Julia Marinissen serves as the Director of the Division of International Health Security
in the Office of Policy and Planning within the Office of the Assistant Secretary for Preparedness
and Response (ASPR) at the U.S. Department of Health and Human Services (HHS). She oversees
and provides leadership in international programs to develop early-warning infectious-disease
surveillance capacity in partner countries and coordinates the development of policies to
provide international assistance during public health emergencies. She also oversees several
international partnerships and serves as the U.S. liaison to the Global Health Security Initiative
(GHSI) and as the chair for the Trilateral Health Security Working Group under the North American Leaders’ Summit
Framework. From 2007–2011, she served as the Executive Secretariat for the GHSI Radiological/Nuclear threats
Working Group. In 2006, Dr. Marinissen joined ASPR as a Science and Technology Policy Fellow sponsored by the
American Association for the Advancement of Science. During the fellowship, she served as a Policy Analyst for the
Biomedical Advanced Research and Development Authority (BARDA) where she was the Executive Director for two
U.S. Government Interagency Working Groups charged with establishing the requirements for medical
countermeasures (MCM) for radiological and nuclear threats, including blood and tissue products. In 2004, she
received the prestigious “Ramon y Cajal” award from the Spanish Ministry of Science and led a research group at the
Universidad Autonoma de Madrid. Her research focused on the effects of inhibitory drugs on Kaposi Sarcoma. She
completed both her Ph.D. and Master Degree in Biology at the Universidad Nacional del Sur in Bahia Blanca,
Argentina, where she also held teaching positions in General Biology and Animal Physiology. From 2003 to 2006, she
served as a U.S. Marine Corps Attaché Spouse at the U.S. Embassy in Madrid, Spain. She routinely organized and
hosted diplomatic events and represented the U.S. at diplomatic, cultural, and military events.

Christopher R. Lissner, PhD M(ASCP), CAPT, MSC, USN (Ret.)

Scientific Director, Armed Forces Radiobiology Research Institute, Bethesda, MD
Dr. Lissner earned a Bachelor of Science in Biological Sciences and a Master of Science in
Cellular & Molecular Biology from the University of Southern California. He later earned a
Doctor of Philosophy in Microbiology from the Uniformed Services University in Bethesda,
Maryland. Over a twenty-six year career in the U.S. Navy’s Medical Service Corps, his positions
included: head of the Microbiology Department at the Naval Medical Center in San Diego and the
National Naval Medical Center in Bethesda; head of the Bacteriology Department at the Naval
Medical Resarch Unit No.3 in Cairo, Egypt; assistant head of the Department of Laboratory
Medicine and Pathology in Bethesda; executive officer at the Naval Medical Research Institute in
Bethesda; and microbiology advisor and community manager for the Office of the Surgeon General, U.S. Navy. After a
very illustrious military career, Dr. Lissner retired at the rank of Navy Captain. Prior to arriving at AFRRI in 2005, he
was director of Sponsored Programs at the Henry M. Jackson Foundation for the Advancement of Military Medicine
and a program director for Peer Review, Congressionally Directed Medical Research Programs, Constella Health
Sciences. Dr. Lissner became the deputy scientific director of AFRRI in 2006 and assumed the position of scientific
director in November of 2008. His professional interests include the diagnosis and treatment of infectious disease,
microbial host parasite relationships, and institutional research administration.

8 of 9 5/2/2011 9:16 PM
IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/speakers.html

BACK TO TOP

To register or to request more information, please contact the Symposium Chairman, Dr. Adarsh
Ramakumar (ramakumar@afrri.usuhs.mil) or Symposium Officer-in-Charge, CPT Ian C. Dews
(dews@afrri.usuhs.mil).

NOTE: Content is subject to change without notice.

Copyright © 2010, 2011 Armed Forces Radiobiology Research Institute (AFRRI)/USUHS. All Rights Reserved.
Designed by AFRRI Automated Cytogenetics Lab (AACL)
AFRRI, 8901 Wisconsin Avenue, Building 42, Bethesda, MD 20889-5603
Privacy Policy | Terms of Use | XHTML | CSS

9 of 9 5/2/2011 9:16 PM
IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/agenda.html

IRIS 2011 Agenda

Home
The Symposium will be held in Lecture Hall D at USUHS, Bethesda, MD; please contact the symposium team if you
Our Purpose require further information.
About AFRRI
Program Committee
Note: The agenda on this page may change and any changes will be prior communicated with the
Calendar participants. To register or to request more information, please contact the Symposium Chairman, Dr.
Agenda Adarsh Ramakumar (ramakumar@afrri.usuhs.mil) or Symposium Officer-in-Charge, CPT Ian C. Dews
Venue & Accomodation (dews@afrri.usuhs.mil).
Conference Speakers
Registration Day 1—Thursday, May 12, 2011
Symposium Participants
Time Event
7:30 a.m. Registration
Abstracts
Welcome
Abstract Guidelines 8:00 a.m.
Dr. Charles Rice, President, USUHS
Submissions
Opening Remarks
Deadlines 8:10 a.m.
COL Mark Melanson, Director, AFRRI
Release Form Introduction
8:20 a.m.
Dr. Adarsh Ramakumar, Chairman, IRIS
Posters
Poster Topics Session 1—Radiation Biology; The Science
Poster Guidelines Chairs: Drs. William Blakely and Carolyn Fisher

Time Event
Radiation biology—From the past 50 years to the next 50 years!
8:30 a.m.
Dr. Sree Kumar, Principal Investigator & Sr. Scientist, AFRRI, Bethesda, MD
Low dose radiation research: What we have learned?
8:55 a.m.
Dr. Noelle Metting, Program Manager, Radiobiology, OBER/DOE, Washington, DC
Radiobiological basis of radiation protection: Standards and inter-laboratory
exercises for emergency preparedness
9:20 a.m.
Dr. Ruth Wilkins, Sr. Scientist Radiobiology, Consumer and Clinical Radiation Protection
Bureau, Health Canada, Ottawa, Canada
Japan radiation incident: A firsthand account of managing a radiation emergency
response
9:45 a.m.
Prof. Mitsuaki Yoshida, Department of Radiation Biology, Institute of Radiation
Emergency Medicine, Hirosaki University, Hirosaki, Japan
10:10 a.m. Break

Session 2—'Omics for Radiation Biology

Chairs: Drs. John Kalinich and Sanchita Ghosh

Time Event
Predictive genomics: A post-genomic integrated approach to analyze biological
signatures of radiation exposure
10:30 a.m.
Prof. Prakash Hande, Department of Physiology, Yong Loo Lin School of Medicine,
National University of Singapore, Singapore
Functional genomics for radiation biology: A gateway to understand cellular stress
responses
10:55 a.m.
Prof. Sally Amundson, Radiation Oncology, Center for Radiological Research, College of
Physicians & Surgeons of Columbia University Medical Center, New York, NY
Metabolomics for radiation biology
Prof. Albert Fornace, Jr., Molecular Cancer Research Chair at Lombardi Comprehensive
11:20 a.m.
Cancer Center; Professor, Department of Biochemistry and Molecular & Cellular Biology,
and Dept. of Oncology, Georgetown, Washington, DC
11:45 a.m. Lunch

1 of 3 5/2/2011 9:17 PM
IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/agenda.html

Session 3—Applied Radiation Biology: Platforms and Technology

Chairs: Drs. Mark H. Whitnall and Shilpa Kulkarni

Time Event
Imageable nanoparticles for radiotherapy applications
1:00 p.m. Dr. William T. Phillips, Nanoparticle Imaging/Therapeutic Systems, Department of
Radiology, University of Texas Health Science Center at San Antonio, San Antonio, TX
Advances in translational radiation biology for improved cancer therapy and
prevention from radiation exposure
1:25 p.m.
Prof. David Boothman, Associate Director for Translational Research, University of Texas
Southwestern Medical Center at Dallas, Dallas, TX
Radiation-induced mitotic catastrophe: Role of RNA binding proteins
1:50 p.m. Prof. Shrikant Anant, Associate Director-Prevention and Cancer Control, Associate Dean
for Research, University of Kansas School of Medicine, Kansas City, KS
Development of novel therapeutic for the treatment of acute radiation syndrome
2:15 p.m.
Dr. Ram Mandalam, President and CEO, Cellerant Therapeutics, San Carlos, CA
2:40 p.m. Break

Session 4—Artificial Intelligence and High-throughput Technologies for Radiation Biology

Chairs: Drs. Lynnette Cary and MAJ Lombardini

Time Event
Need for infrastructure and high-throughput technologies to manage radiation data
in a mass casualty
3:00 p.m.
Dr. Gordon Livingston, Technical Director, Cytogenetic Biodosimetry Laboratory,
REAC/TS, ORISE & ORAU, Oak Ridge, TN
Artificial Intelligence-assisted automated cytogenetics
3:25 p.m. Dr. Adarsh Ramakumar, Principal Investigator & Sr. Bioinformatics, Biostatistics and
Biomedical Analyst, AFRRI, Bethesda, MD
Novel image segmentation approaches for automated identification of chromosome
abnormalities due to radiation exposure
3:50 p.m.
Peter Rogan, Canada Research Chair in Genome Bioinformatics, Tier I, Professor of
Biochemistry & Computer Science, University of Western Ontario, Ontario, Canada
Nanoprobes and molecular high-throughput imaging approaches in theragnostics
4:15 p.m. Prof. Dr. Rao Papineni, Sr. Principal Investigator, Research and Development,
Carestream Molecular Imaging, Woodbridge, CT
4:40 p.m. Adjourn

Day 2—Friday, May 13, 2011

Session 5—Technologies and Applications for Radiation Biology
Chairs: Drs. Julian Kiang and CPT Ian C. Dews

Time Event
Novel technology approaches for radiation repair
8:15 a.m. Prof. Chandan Guha, Vice Chair, Department of Radiation Oncology Montefiore Medical
Center, Bronx, NY
Proteomics for radiation biomarker discovery
8:40 a.m. Prof. Harvey Pollard, Chair, Department of Anatomy, Physiology and Genetics, USUHS,
Bethesda, MD
The advances of nanotechnology as applied to radiation biology
9:05 a.m. Prof. Sunil Krishnan, Department of Radiation Oncology, Division of Radiation Oncology,
The University of Texas, MD Anderson Cancer Center, Houston, TX
Mircofluidics applications for protein expression analysis and molecular diagnostics
9:30 a.m. Dr. Seth Cohen, Senior Director, Microfluidic Applications & Support, Caliper Life
Sciences, Hopkinton, MA
Mircofluidics and advances in technology for radiation biology
9:55 a.m. Prof. Frederic Zenhausen, Director, Center for Applied Nanobioscience and Medicine,
College of Medicine Phoenix, University of Arizona, Tucson, AZ
10:20 a.m. Break

Session 6—Technology Blitz

Chairs: Drs. Michael Landauer and Lt Col Michael Dempsey

Time Event
Bioelectric strategies and applications for radiation biology
10:40 a.m.
Dr. Erik Young, Center for Radiological Research, Columbia University, New York, NY
qNPA assay technology for gene expression signature development
11:05 a.m.
Dr. Bruce Seligmann, Chief Scientific Officer, High Throughput Genomics, Tucson, AZ
Harnessing cloud computing for Radioinformatics
11:30 a.m.
Dr. Ramesh Rangachar, Sr. Project Head, Intelsat, Washington, DC

2 of 3 5/2/2011 9:17 PM
IRIS 2011 - International Radio-Informatics Symposium 2011 - AFRRI - ... http://www.usuhs.mil/afrrianniversary/events/informatics/agenda.html

Time Event
Application of cloud computing for data analysis
11:55 a.m. Prof. Robert Grossman*, Institute for Genomics and Systems Biology, Department of
Medicine, Genetic Medicine at the University of Chicago, Chicago, IL
12:20 p.m. Lunch

Session 7—Governing the Science of Tomorrow!

Chairs: Drs. Pataje Prasanna and Steve Kaminsky

Time Event
Overview of DOE systems biology knowledgebase and initiatives
1:40 p.m.
Dr. Susan Gregurick, Program Director, OBER/DOE, Washington DC
Overview of Biomedical Advanced Research and Development Authority (BARDA)
programs
2:00 p.m.
Dr. Richard Hatchet, Chief Medical Officer & Deputy Director, HHS/OS/ASPR/ BARDA,
Washington, DC
Overview of NIAID’s Radiation/Nuclear Medical Countermeasures Development
2:20 p.m. Program
Dr. Bert Maidment, Associate Director, Product Development NIAID/NIH, Rockville, MD
Overview and policy of Office of Assistant Secretary for Preparedness and Response,
USA
2:40 p.m.
Dr. Maria Julia Marinissen, Director, Division of International Health Security, HHS,
Washington DC
3:00 p.m. Break

Time Event
Panel discussion: Forming the road map for Radioinformatics application
development
3:20 p.m.
A six member panel of distinguished people will be announced separately.
Convenor: Dr. Christopher Lissner, Scientific Director, AFRRI
Closing remarks
5:00 p.m.
COL Mark A. Melanson, Director, AFRRI
Vote of thanks
5:10 p.m.
Dr. Adarsh Ramakumar, Chairman, IRIS

Further information about the venue and accomodation is available elsewhere on this site.

To register or to request more information, please contact the Symposium Chairman, Dr. Adarsh
Ramakumar (ramakumar@afrri.usuhs.mil) or Symposium Officer-in-Charge, CPT Ian C. Dews
(dews@afrri.usuhs.mil).

NOTE: Content is subject to change without notice.

Copyright © 2010, 2011 Armed Forces Radiobiology Research Institute (AFRRI)/USUHS. All Rights Reserved.
Designed by AFRRI Automated Cytogenetics Lab (AACL)
AFRRI, 8901 Wisconsin Avenue, Building 42, Bethesda, MD 20889-5603
Privacy Policy | Terms of Use | XHTML | CSS

3 of 3 5/2/2011 9:17 PM